clinical trial · NCT07632898

Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

$IKT →·phase3·not yet recruiting·n = 484

Pulmonary Arterial Hypertension (PAH)IKT-001

brief summary

This is a multicenter, open-label extension (OLE), single-arm study designed to assess the long-term safety and tolerability of oral IKT-001 administered once daily.

started

Oct 23, 2026

primary completion

Jun 30, 2030

completion

Dec 30, 2030

last updated

Jun 8, 2026

official title

Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability of IKT-001 in Pulmonary Arterial Hypertension

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol